Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Blocking JAK-STAT5 signaling in mice leads to hair growth.

Suppressing ODC activity reduces tumor growth in hair follicles.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

JAK inhibitors partially restore scalp bacteria balance in alopecia areata patients.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

A new method accurately detects illegal JAK inhibitors in hair loss cosmetics.

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.

Finasteride helps female-pattern hair loss.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

IL-1β inhibits human hair follicle growth.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Tofacitinib helped a woman regrow hair with no major side effects.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.